Press Releases

Date Title View
Toggle SummaryNovember 2, 2010 GenMark Diagnostics Acquires License to HCV Genotyping Patent Estate View HTML
Toggle SummaryOctober 18, 2010 GenMark Diagnostics Schedules Third Quarter Earnings Release and Conference Call for November 4, 2010 View HTML
Toggle SummaryOctober 1, 2010 GenMark Diagnostics to Present at William Blair Emerging Growth Stock Conference View HTML
Toggle SummarySeptember 27, 2010 GenMark Diagnostics Selected as Diagnostic Platform in Warfarin Clinical Trial View HTML
Toggle SummarySeptember 1, 2010 GenMark Diagnostics Appoints James Fox, Ph.D., to Board of Directors View HTML
Toggle SummaryAugust 9, 2010 GenMark Reports Second Quarter Results
Revenues Increase 162% over Prior YearSystem Placements Increase by Twelve to Twenty Year-to-DateDr. Jon Faiz Kayyem appointed Chief Scientific OfficerChristopher Gleeson appointed Interim CEO
View HTML
Toggle SummaryJuly 22, 2010 GenMark Diagnostics Schedules Second Quarter Earnings Release and Conference Call for August 9, 2010 View HTML
Toggle SummaryMay 28, 2010 GenMark Announces Pricing of Its Initial Public Offering View HTML